4//SEC Filing
Seth Kiernan 4
Accession 0001127602-23-007932
CIK 0001062822other
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 4:55 PM ET
Size
15.5 KB
Accession
0001127602-23-007932
Insider Transaction Report
Form 4
Seth Kiernan
VP, Chief Commercial Officer
Transactions
- Exercise/Conversion
Common Stock
2023-02-28+5,286→ 41,986 total - Exercise/Conversion
Restricted Stock Units
2023-02-28−22,963→ 45,927 total→ Common Stock (22,963 underlying) - Exercise/Conversion
Common Stock
2023-02-28+14,833→ 36,700 total - Exercise/Conversion
Common Stock
2023-02-28+22,963→ 64,949 total - Exercise/Conversion
Restricted Stock Units
2023-02-28−14,833→ 0 total→ Common Stock (14,833 underlying) - Tax Payment
Common Stock
2023-02-28$2.17/sh−11,813$25,634→ 53,136 total - Exercise/Conversion
Restricted Stock Units
2023-02-28−5,286→ 5,287 total→ Common Stock (5,286 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock.
- [F2]Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
- [F3]Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.
Documents
Issuer
LEXICON PHARMACEUTICALS, INC.
CIK 0001062822
Entity typeother
Related Parties
1- filerCIK 0001890439
Filing Metadata
- Form type
- 4
- Filed
- Feb 28, 7:00 PM ET
- Accepted
- Mar 1, 4:55 PM ET
- Size
- 15.5 KB